129 related articles for article (PubMed ID: 5802725)
21. [Immunology of malignant melanoma. Current data].
Pavie-Fischer J; Kourilsky FM
Rev Prat; 1975 Nov; 25(51):4027-8, 4031-3. PubMed ID: 1209142
[No Abstract] [Full Text] [Related]
22. [Experimental induction of the delayed reaction as immunologica indicator (in dermatoses, tumors, immunosuppression)].
Remy W; Stüttgen G
Allerg Immunol (Leipz); 1972; 18(2):97-104. PubMed ID: 4266967
[No Abstract] [Full Text] [Related]
23. [Evaluation of cellular immunity in melanoma by means of a modified leukocyte migration inhibition test].
Bowszyc J; Bowszyc J; Wojnerowicz-Grajewska M; Milanowski L
Przegl Dermatol; 1980; 67(3):319-23. PubMed ID: 6968922
[No Abstract] [Full Text] [Related]
24. Long-term spontaneous regression of malignant melanoma with visceral metastases. Report of a case with immunologic profile.
Bulkley GB; Cohen MH; Banks PM; Char DH; Ketcham AS
Cancer; 1975 Aug; 36(2):485-94. PubMed ID: 1157014
[TBL] [Abstract][Full Text] [Related]
25. Melanoma prognostic factors found in the dermatopathology report.
Payette MJ; Katz M; Grant-Kels JM
Clin Dermatol; 2009; 27(1):53-74. PubMed ID: 19095154
[TBL] [Abstract][Full Text] [Related]
26. Editorial: Spontaneous regression of primary cutaneous melanoma.
Med J Aust; 1975 Nov; 2(20):761. PubMed ID: 1214687
[No Abstract] [Full Text] [Related]
27. Cellular immunity to breast carcinoma and malignant melanoma.
Cochran AJ; Mackie RM; Thomas CE; Grant RM; Cameron-Mowat DE; Spilg WG
Br J Cancer Suppl; 1973 Aug; 1():77-82. PubMed ID: 4804293
[TBL] [Abstract][Full Text] [Related]
28. Cellular reaction to concanavalin A studied by the skin window method in healthy subjects and in patients with malignant tumors.
Kolár Z; Jansa P; Kovarík J; Skovránková H; Krcová I
Acta Univ Palacki Olomuc Fac Med; 1987; 117():73-80. PubMed ID: 2977713
[No Abstract] [Full Text] [Related]
29. Immunotherapy of advanced or metastatic melanoma.
Cebon J; Gedye C; John T; Davis ID
Clin Adv Hematol Oncol; 2007 Dec; 5(12):994-1006. PubMed ID: 18277962
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
[TBL] [Abstract][Full Text] [Related]
31. Uveitis caused by cytotoxic immune response to cutaneous malignant melanoma in swine: destruction of uveal melanocytes during tumor regression.
Lentz KJ; Burns RP; Loeffler K; Feeney-Burns L; Berkelhammer J; Hook RR
Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1063-9. PubMed ID: 6874271
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
Serov AA; Kadagidze ZG
Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
[TBL] [Abstract][Full Text] [Related]
33. Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine.
O'Rourke MG; Johnson M; Lanagan C; See J; Yang J; Bell JR; Slater GJ; Kerr BM; Crowe B; Purdie DM; Elliott SL; Ellem KA; Schmidt CW
Cancer Immunol Immunother; 2003 Jun; 52(6):387-95. PubMed ID: 12682787
[TBL] [Abstract][Full Text] [Related]
34. Complete regression of primary malignant melanoma.
Emanuel PO; Mannion M; Phelps RG
Am J Dermatopathol; 2008 Apr; 30(2):178-81. PubMed ID: 18360126
[TBL] [Abstract][Full Text] [Related]
35. Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi.
Kornstein MJ; Brooks JS; Elder DE
Cancer Res; 1983 Jun; 43(6):2749-53. PubMed ID: 6342758
[TBL] [Abstract][Full Text] [Related]
36. [Anatomo-clinical criteria of cutaneous melanoma with spontaneous and complete regression. Apropos of a case].
Saint-Blancard P; Nottet JB; Lanternier G; Le Guyadec T; Gouteyron JF; Le Vagueresse R
Arch Anat Cytol Pathol; 1997; 45(4):234-7. PubMed ID: 9406484
[TBL] [Abstract][Full Text] [Related]
37. Spontaneous regression of metastases from malignant melanoma: a case report.
Kalialis LV; Drzewiecki KT; Mohammadi M; Mehlsen AB; Klyver H
Melanoma Res; 2008 Aug; 18(4):279-83. PubMed ID: 18626313
[TBL] [Abstract][Full Text] [Related]
38. [Immunological aspects of the melanoma].
Rümke P
Ned Tijdschr Geneeskd; 1969 Jan; 113(2):76-7. PubMed ID: 5762484
[No Abstract] [Full Text] [Related]
39. Up in smoke.
McCalmont TH
J Cutan Pathol; 2010 Jul; 37(7):720-2. PubMed ID: 20602664
[No Abstract] [Full Text] [Related]
40. [Spontaneous local regression of a metastasic and fatal melanoma].
Parache RM; Chardot C
Presse Med (1893); 1969 Dec; 77(54):2059-60. PubMed ID: 5378466
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
